| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1377156 | Bioorganic & Medicinal Chemistry Letters | 2007 | 6 Pages |
Abstract
A high throughput screening campaign revealed compound 1 as a potent antagonist of the human CCK1 receptor. Here, we report the syntheses and SAR studies of 1,5-diarylpyrazole analogs with various structural modifications of the alkane side chain of the molecule. The difference in affinity between the two enantiomers for the CCK1 receptor and the flexible nature of the linker led to the design of constrained analogs with increased potency.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Laurent Gomez, Michael D. Hack, Kelly McClure, Clark Sehon, Liming Huang, Magda Morton, Lina Li, Terrance D. Barrett, Nigel Shankley, J. Guy Breitenbucher,